Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
109.6 USD | +0.05% | +1.21% | +74.92% |
May. 23 | U.S. FDA advisers back approval for Guardant's cancer test | RE |
May. 14 | Piper Sandler Adjusts Price Target on Natera to $120 From $110, Maintains Overweight Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+74.92% | 13.46B | |
+17.73% | 83.46B | |
-32.08% | 67.33B | |
-2.32% | 25.66B | |
+3.56% | 17.91B | |
-13.68% | 16.54B | |
+0.75% | 15.43B | |
+73.16% | 12.78B | |
-2.02% | 12.33B | |
+1.71% | 12.55B |
- Stock Market
- Equities
- NTRA Stock
- News Natera, Inc.
- BTIG Raises Price Target on Natera to $125 From $100, Maintains Buy Rating